|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/593 | |
| A61K 31/454 | |||
| A61K 31/45 | |||
| G01N 33/50 |
| (11) | Patento numeris | 2504703 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10833897.1 |
| Europos patento paraiškos padavimo data | 2010-11-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-10-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-11-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/057951 |
| Data | 2010-11-24 |
| (87) | Numeris | WO 2011/066351 |
| Data | 2011-06-03 |
| (30) | Numeris | Data | Šalis |
| 264062 P | 2009-11-24 | US | |
| 324473 P | 2010-04-15 | US |
| (72) |
BROSSEAU, Carole, FR
BARTLETT, Justin, Blake, US
DALGLEISH, Angus, George, GB
COLSTON, Kay, Winifred, GB
GALUSTIAN, Christine, GB
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | IMMUNOMODULATORY COMPOUNDS FOR THE RESTORATION OF VITAMIN D SENSITIVITY IN VITAMIN D RESISTANT TUMOR CELLS |
| IMMUNOMODULATORY COMPOUNDS FOR THE RESTORATION OF VITAMIN D SENSITIVITY IN VITAMIN D RESISTANT TUMOR CELLS |